1. Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and
2. Infection Sciences, Synnovis, London, United Kingdom;
3. Department of Infectious Diseases and
4. Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom;
5. Critical Care Directorate, Guy’s and St Thomas’ NHS Foundation Trust, London, England;
6. London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom;
7. UK Health Security Agency, London, United Kingdom; and
8. Oxford Nanopore Technologies, Oxford, United Kingdom.